Streetbeat News

Stock Prices

PRSO

Peraso (NASDAQ:PRSO) reported Q4 EPS of $(8.52), missing the $(3.76) estimate by 126.6%, and a 63.85% decrease from last year's $(5.20) per share. Sales were $1.83M, beating the $1.70M estimate by 7.76%, but down 52.87% from last year's $3.89M.

Portfolio Pulse from dijoy@benzinga.com

March 18, 2024 | 8:36 pm

ACXP

Acurx Pharmaceuticals' shares have declined following the company's announcement of a common stock offering. This move typically dilutes existing shareholders' value, leading to a negative reaction in the stock market.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:35 pm

NCMI

National CineMedia (NCMI) shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:33 pm

DRQ

Dril-Quip, Inc. (DRQ) and Innovex Downhole Solutions have agreed to merge in an all-stock transaction. Post-merger, DRQ stockholders will own about 52% and Innovex stockholders about 48% of the new entity. The deal is expected to be immediately accretive to earnings and free cash flow.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:32 pm

STNE

StoneCo's shares have declined following the announcement of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:32 pm

STNE

StoneCo reported Q4 sales of R$3.25 billion, missing the estimated R$3.42 billion. This correction highlights a shortfall in the company's expected revenue.

Portfolio Pulse from Benzinga Newsdesk

March 18, 2024 | 8:31 pm

LTRN

Lantern Pharma (NASDAQ:LTRN) reported Q4 earnings, beating estimated earnings by 3.0% with an EPS of $-0.39 versus an estimate of $-0.4. However, revenue was unchanged from the same period last year. Following last quarter's earnings beat, the share price increased by 33.0% the next day.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 8:30 pm

HUM

Over the past 15 years, Humana (NYSE:HUM) has produced an average annual return of 19.3%, outperforming the market by 6.17% on an annualized basis. A $100 investment in HUM 15 years ago would now be worth $1,359.93. Humana's market capitalization currently stands at $41.85 billion.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 8:30 pm

RAIL

FreightCar America (NASDAQ:RAIL) reported Q4 earnings with an EPS of $-0.07, missing estimates by -600% and a revenue decrease of $2.38M from the previous year. The company's share price dropped 7% the day after last quarter's earnings miss.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 8:30 pm

RAIL

FreightCar America (NASDAQ:RAIL) reported Q4 earnings with a loss of $(0.07) per share, missing the $(0.01) estimate by 600%. Sales were $126.60M, missing the $135.00M estimate by 6.22%, marking a 1.85% decrease from the previous year.

Portfolio Pulse from dijoy@benzinga.com

March 18, 2024 | 8:29 pm